Literature DB >> 17573518

Double trouble for 2,609 hospitalized medical patients who developed deep vein thrombosis: prophylaxis omitted more often and pulmonary embolism more frequent.

Gregory Piazza1, Ali Seddighzadeh, Samuel Z Goldhaber.   

Abstract

BACKGROUND: Hospitalized patients with medical illness are especially susceptible to the development of venous thromboembolism (VTE).
METHODS: To improve our understanding of the demographics, comorbidities, risk factors, clinical presentation, prophylaxis, and treatment of hospitalized medical patients with deep vein thrombosis (DVT), we evaluated hospitalized medical patients in a prospective registry of 5,451 consecutive ultrasound-confirmed DVT patients at 183 institutions in the United States.
RESULTS: Of those patients who participated in the registry, 2,609 (48%) were hospitalized medical patients. Compared with 1,953 hospitalized nonmedical patients with DVT, medical patients with DVT experienced pulmonary embolism (PE) more often (22.2% vs 15.5%, respectively; p < 0.0001). However, medical patients in whom DVT developed had received VTE prophylaxis far less frequently than nonmedical patients (25.4% vs 53.8%, respectively; p < 0.0001). The underutilization of VTE prophylaxis among hospitalized medical patients extended to both pharmacologic and mechanical modalities. In a multivariable logistic regression analysis of all hospitalized VTE patients, status as a medical patient was negatively associated with receiving prophylaxis (adjusted odds ratio, 0.47; 95% confidence interval, 0.28 to 0.78).
CONCLUSIONS: Hospitalized medical patients face "double trouble." First, during hospitalization for a reason other than VTE, VTE prophylaxis is omitted in medical patients more often than in nonmedical patients. Second, when VTE develops as a complication of hospitalization, hospitalized medical patients experience PE more often. Further studies should focus on understanding why prophylaxis is often omitted in hospitalized medical patients and on improving its implementation in this vulnerable population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17573518     DOI: 10.1378/chest.07-0430

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  18 in total

Review 1.  Venous thromboembolism prophylaxis with unfractionated heparin in the hospitalized medical patient: the case for thrice daily over twice daily dosing.

Authors:  Charles E Mahan; Mario Pini; Alex C Spyropoulos
Journal:  Intern Emerg Med       Date:  2010-02-23       Impact factor: 3.397

2.  Risk Stratification Model: Lower-Extremity Ultrasonography for Hospitalized Patients with Suspected Deep Vein Thrombosis.

Authors:  Emily C Alper; Ivan K Ip; Patricia Balthazar; Gregory Piazza; Samuel Z Goldhaber; Carol B Benson; Ronilda Lacson; Ramin Khorasani
Journal:  J Gen Intern Med       Date:  2017-09-15       Impact factor: 5.128

3.  The AVAIL ME study: a multinational survey of VTE risk and prophylaxis.

Authors:  Ali T Taher; Joseph Aoun; Pascale Salameh
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

Review 4.  Prevention of venous thromboembolism with new oral anticoagulants versus standard pharmacological treatment in acute medically ill patients: a systematic review and meta-analysis.

Authors:  Ida Ehlers Albertsen; Torben Bjerregaard Larsen; Lars Hvilsted Rasmussen; Thure Filskov Overvad; Gregory Y H Lip
Journal:  Drugs       Date:  2012-09-10       Impact factor: 9.546

Review 5.  Rationale supporting an "opt-out" policy for pharmacological venous thromboembolism prophylaxis in hospitalized medical patients.

Authors:  Samuel Z Goldhaber
Journal:  J Thromb Thrombolysis       Date:  2013-04       Impact factor: 2.300

Review 6.  Physician alerts to prevent venous thromboembolism.

Authors:  Gregory Piazza; Samuel Z Goldhaber
Journal:  J Thromb Thrombolysis       Date:  2010-07       Impact factor: 2.300

7.  Venous thromboembolic events in hospitalised medical patients.

Authors:  Gregory Piazza; John Fanikos; Maksim Zayaruzny; Samuel Z Goldhaber
Journal:  Thromb Haemost       Date:  2009-09       Impact factor: 5.249

8.  Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patients.

Authors:  Gregory Piazza; Erin J Rosenbaum; William Pendergast; Joseph O Jacobson; Robert C Pendleton; Gordon D McLaren; C Gregory Elliott; Scott M Stevens; William F Patton; Ousama Dabbagh; Marilyn D Paterno; Elaine Catapane; Zhongzhen Li; Samuel Z Goldhaber
Journal:  Circulation       Date:  2009-04-13       Impact factor: 29.690

Review 9.  Current issues in thromboprophylaxis in the elderly.

Authors:  Parminder S Chaggar; Kevin S Channer
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

10.  Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start).

Authors:  A Amin; A C Spyropoulos; P Dobesh; A Shorr; M Hussein; E Mozaffari; J S Benner
Journal:  J Thromb Thrombolysis       Date:  2010-04       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.